This repair capacity (RECAP) test found that 19% of the unselected primary breast tumors (out of 125 breast cancer cases) showed a HRD phenotype, which could be explained by BRCA1/2 mutations or BRCA1 promoter hypermethylation in most cases [62,63]. The gene discussed is BRCA1; the disease is breast cancer.